摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-<1,2-dihydro-1-oxo-9-<2-(trimethylsilyl)ethynyl>benzoquinazolin-3-yl>pivalamide | 139988-20-8

中文名称
——
中文别名
——
英文名称
N-<1,2-dihydro-1-oxo-9-<2-(trimethylsilyl)ethynyl>benzoquinazolin-3-yl>pivalamide
英文别名
N-(1,2-dihydro-1-oxo-9-(2-(trimethylsilyl)ethynyl)benzo[f]quinazolin-3-yl)pivalamide;N-(1,2-dihydro-1-oxo-9-(trimethylsilylethynyl)benzo[f]quinazolin-3-yl)pivalamide;2,2-dimethyl-N-[1-oxo-9-(2-trimethylsilylethynyl)-2H-benzo[f]quinazolin-3-yl]propanamide
N-<1,2-dihydro-1-oxo-9-<2-(trimethylsilyl)ethynyl>benzo<f>quinazolin-3-yl>pivalamide化学式
CAS
139988-20-8
化学式
C22H25N3O2Si
mdl
——
分子量
391.545
InChiKey
AVBFLDWZBMRUGQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.12±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.29
  • 重原子数:
    28
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    70.6
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-<1,2-dihydro-1-oxo-9-<2-(trimethylsilyl)ethynyl>benzoquinazolin-3-yl>pivalamide 在 palladium on activated charcoal 甲醇sodium hydroxide 、 Lindlar's catalyst 、 氢气potassium carbonate 作用下, 以 甲醇乙醇 为溶剂, 反应 5.67h, 生成 3-amino-9-ethylbenzo[f]quinazolin-1(2H)-one
    参考文献:
    名称:
    Benzoquinazoline inhibitors of thymidylate synthase: enzyme inhibitory activity and cytotoxicity of some 3-amino- and 3-methylbenzo[f]quinazolin-1(2H)-ones
    摘要:
    The synthesis and thymidylate synthase (TS) inhibitory activity of a series of simple benzo-[f]-quinazolin-1(2H)-ones are described. Fully aromatic 3-amino compounds with compact lipophilic substituents in the 9-position were found to have I50 values as low as 20 nM on the isolated enzyme, and represent the first examples of potent, folate-based TS inhibitors that completely lack any structural feature corresponding to the (p-aminobenzoyl)glutamate moiety of the cofactor. A number of the compounds also showed moderate growth inhibitory activity against a human colon adenocarcinoma cell line (SW480), with IC50 values as low as 2 muM.
    DOI:
    10.1021/jm00068a004
  • 作为产物:
    描述:
    7-溴-3,4-二氢-1H-2-萘酮吡啶 、 palladium diacetate 、 N-溴代丁二酰亚胺(NBS)sodium ethanolate 、 sodium hydride 、 三乙胺三苯基膦 作用下, 以 乙醇乙腈 为溶剂, 反应 49.75h, 生成 N-<1,2-dihydro-1-oxo-9-<2-(trimethylsilyl)ethynyl>benzoquinazolin-3-yl>pivalamide
    参考文献:
    名称:
    Benzoquinazoline inhibitors of thymidylate synthase: enzyme inhibitory activity and cytotoxicity of some 3-amino- and 3-methylbenzo[f]quinazolin-1(2H)-ones
    摘要:
    The synthesis and thymidylate synthase (TS) inhibitory activity of a series of simple benzo-[f]-quinazolin-1(2H)-ones are described. Fully aromatic 3-amino compounds with compact lipophilic substituents in the 9-position were found to have I50 values as low as 20 nM on the isolated enzyme, and represent the first examples of potent, folate-based TS inhibitors that completely lack any structural feature corresponding to the (p-aminobenzoyl)glutamate moiety of the cofactor. A number of the compounds also showed moderate growth inhibitory activity against a human colon adenocarcinoma cell line (SW480), with IC50 values as low as 2 muM.
    DOI:
    10.1021/jm00068a004
点击查看最新优质反应信息

文献信息

  • Pharmaceutical compounds
    申请人:Burroughs Wellcome Co.
    公开号:US05405851A1
    公开(公告)日:1995-04-11
    The present invention relates to novel benzoquinazoline thymidylate synthase inhibitors, to pharmaceutical formulations containing them and to their use in medicine.
    本发明涉及新型苯并喹啉嘧啶酸合酶抑制剂、包含它们的制药配方以及它们在医学上的使用。
  • Treatment of cancer with pharmaceutically active benzoquinazoline
    申请人:Glaxo Wellcome Inc.
    公开号:US05661155A1
    公开(公告)日:1997-08-26
    The present invention relates to bezoquinazoline thymidylate synthase inhibitors, to pharmaceutical formulations containing them and to their use in medicine.
    本发明涉及苯二氮杂喹嗪嘧啶酸合成酶抑制剂,含有它们的制药配方以及它们在医学上的使用。
  • Pharmaceutically active benzoquinazoline compounds
    申请人:THE WELLCOME FOUNDATION LIMITED
    公开号:EP1199307B1
    公开(公告)日:2004-02-25
  • Benzoquinazoline inhibitors of thymidylate synthase: enzyme inhibitory activity and cytotoxicity of some 3-amino- and 3-methylbenzo[f]quinazolin-1(2H)-ones
    作者:William Pendergast、Jay V. Johnson、Scott H. Dickerson、Inderjit K. Dev、David S. Duch、Robert Ferone、William R. Hall、Joan Humphreys、Joseph M. Kelly、David C. Wilson
    DOI:10.1021/jm00068a004
    日期:1993.8
    The synthesis and thymidylate synthase (TS) inhibitory activity of a series of simple benzo-[f]-quinazolin-1(2H)-ones are described. Fully aromatic 3-amino compounds with compact lipophilic substituents in the 9-position were found to have I50 values as low as 20 nM on the isolated enzyme, and represent the first examples of potent, folate-based TS inhibitors that completely lack any structural feature corresponding to the (p-aminobenzoyl)glutamate moiety of the cofactor. A number of the compounds also showed moderate growth inhibitory activity against a human colon adenocarcinoma cell line (SW480), with IC50 values as low as 2 muM.
查看更多